Archive | Journal Articles

RSS feed for this section

User experience analysis of an eHealth system for tuberculosis in resource-constrained settings: A nine-country comparison

Konduri N, Bastos LGV, Sawyer K, Reciolino LFA. User experience analysis of an eHealth system for tuberculosis in resource-constrained settings: A nine-country comparison. International Journal of Medical Informatics 102 2017; 118-29.

Read the full article

Read full story · Comments are closed

Individual capacity-building approaches in a global pharmaceutical systems strengthening program: a selected review

Konduri N, Rauscher M. Shio-Chu JW, Malpica-Llanos T. Individual capacity-building approaches in a global pharmaceutical systems strengthening program: a selected review. Journal of Pharmaceutical Policy and Practice 2017;10:16.

Read the full article

Read full story · Comments are closed

User experience analysis of e-TB Manager, a nationwide electronic tuberculosis recording and reporting system in Ukraine

Konduri N, Sawyer K, Nizova N. User experience analysis of e-TB Manager, a nationwide electronic tuberculosis recording and reporting system in Ukraine. European Respiratory Journal Open Research 3;2017: 00002-2017.

Read the full article

Read full story · Comments are closed

An analysis of policies for cotrimoxazole, amoxicillin and azithromycin use in Namibia’s public sector: Findings and therapeutic implications

Kibuule, D., Mubita, M., Naikaku, E., Kalemeera, F., Godman, B. B. and Sagwa, E. (2017), An analysis of policies for cotrimoxazole, amoxicillin and azithromycin use in Namibia’s public sector: Findings and therapeutic implications. Int J Clin Pract. doi:10.1111/ijcp.12918

Access the full article 

Read full story · Comments are closed

Engagement of the private pharmaceutical sector for TB control: rhetoric or reality?

Konduri N, Delmotte E, Rutta E. Engagement of the private pharmaceutical sector for TB control: Rhetoric or reality? Journal: Journal of Pharmaceutical Policy and Practice, 2017, Volume 10, Number 1

Read the full article

Read full story · Comments are closed

Assessment of the World Health Organization’s HIV Drug Resistance Early Warning Indicators in Main and Decentralized Outreach Antiretroviral Therapy Sites in Namibia

Mutenda N, Bukowski A, Nitschke AM, Nakanyala T, Hamunime N, Mekonen T, Tjituka F, Mazibuko G, Mwinga S, Mabirizi D, Sagwa E, Indongo R, Dean N, Jordan MR, Hong SY. Assessment of the World Health Organization’s HIV drug resistance early warning indicators in main and decentralized outreach antiretroviral therapy sites in Namibia. PLOS One. 2016.

Read the full article

 

Read full story · Comments are closed

Sentinel site active surveillance of safety of first-line antiretroviral medicines in Namibia

Mann M, Mengistu A, Gaeseb J, Sagwa E, Mazibuko G, Baeten JM, Babigumira JB, Garrison LP, Stergachis A. Sentinel site active surveillance of safety of first-line antiretroviral medicines in Namibia. Pharmacoepidemiology and Drug Safety. 2016, Vol 25, Issue 9; 1052-1060.

Read the full article

Read full story · Comments are closed

Active Surveillance versus Spontaneous Reporting for First-Line Antiretroviral Medicines in Namibia: A Cost-Utility Analysis

Mann M, Mengistu A, Gaeseb J, Sagwa E, Mazibuko G, Babigumira JB, Garrison Jr LP, Stergachis A. Active surveillance versus spontaneous reporting for first-line antiretroviral medicines in Namibia: A cost-utility analysis. Drug Safety. 2016, Vol. 39, Issue 9; 859-872.

Read the full article

 

Read full story · Comments are closed

Defining pharmaceutical systems strengthening: concepts to enable measurement

Hafner T, Walkowiak H, Lee D, Aboagye-Nyame F. Defining pharmaceutical systems strengthening: Concepts to enable measurement. Health Policy and Planning Advance Access. 2016; 1-13.

Read the full article

 

Read full story · Comments are closed

The tuberculosis profile of the Philippines, 2003–2011: advancing DOTS and beyond

Vianzon R, Celina Garfin AM, Lagos A, Belen R. The tuberculosis profile of the Philippines, 2003-2011: Advancing DOTS and beyond. Surveillance Report. 2013.

Read the full article

Read full story · Comments are closed